The medicalization of menopause: critique and consequences

Int J Health Serv. 2001;31(4):769-92. doi: 10.2190/M77D-YV2Y-D5NU-FXNW.

Abstract

Menopause is in the process of becoming medicalized. Midlife and older women are being told that natural menopause is actually a deficiency condition requiring replacement hormones to maintain health and increase longevity. The three major diseases that are being linked with the lower estrogen levels of midlife and older women are heart disease, osteoporosis and, most recently, Alzheimer's disease. Primary prevention of these diseases is the rationale used for urging healthy women to take long-term hormones. Although there have been many challenges to these links and warnings against the widespread use of hormones, they have been either ignored or trivialized. In this article, the author examines mortality and morbidity statistics across and within nations and over time, critiques the major arguments used to support the notion that menopause places women at an increased risk of disease and that exogenous hormones reduce this risk, and discusses the adverse consequences of defining all midlife and older women as hormonally deficient and in need of medical intervention.

Publication types

  • Review

MeSH terms

  • Aged
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / prevention & control
  • Attitude to Health*
  • Climacteric / physiology
  • Climacteric / psychology*
  • Epidemiologic Studies
  • Estrogen Replacement Therapy* / adverse effects
  • Estrogen Replacement Therapy* / psychology
  • Female
  • Heart Diseases / mortality
  • Heart Diseases / prevention & control
  • Humans
  • Menopause / physiology
  • Menopause / psychology*
  • Middle Aged
  • Osteoporosis / epidemiology
  • Osteoporosis / prevention & control
  • Primary Prevention
  • Risk Factors
  • Sociology, Medical*
  • Women's Health*